Data Platform Strategy
Advising organizations on how to design, build and scale scientific data platforms that meet the real needs of research and discovery teams.
Board & advisory
Board Member and Advisor
Scientific informatics, drug discovery data platforms, international expansion and commercial scale — viewed from both the established category leader and the next generation.
Board-level value
Perspective earned inside the category.
Richard brings more than 30 years of scientific informatics experience to boards and leadership teams. At Dotmatics he helped turn specialist scientific software into a global commercial operation, growing revenue from £4 million to £16 million in three years. At Adroit AI, he is applying those lessons to the data demands now reshaping discovery.
4×Dotmatics revenue growth in three years
2×International commercial team growth
30+Years across scientific software and data
Governance & board-level value
International Expansion
Supporting life sciences technology companies entering or scaling across international markets, with particular depth in European and global commercial operations.
AI Adoption in Drug Discovery
Helping organizations evaluate and implement AI tools within drug discovery workflows, with a focus on practical outcomes over theoretical capability.
Commercial Leadership Development
Guiding senior commercial leaders in scientific and technical organizations on strategy, team structure and execution in complex markets.
Go-to-Market Strategy
Working with founders and executive teams to develop go-to-market approaches for scientific informatics and life sciences technology products.
A distinctive point of view
He knows what made the last generation work.
Richard understands the customer relationships, scientific credibility, implementation realities and commercial discipline that helped Dotmatics scale. That gives him a rare ability to distinguish durable platform value from fashionable claims — and to recognise when research organisations are ready for a new approach.
His advice is grounded in the practical choices that determine whether complex scientific technology earns trust, scales internationally and becomes embedded in everyday discovery.
“The best boards ask the questions that the leadership team is too close to the problem to ask themselves.”Discuss a board role